The weight loss drug Belviq is being pulled from the market because of a slight increased risk of cancer. The drug's maker, Japan’s Eisai Inc., said Thursday that it has agreed to voluntarily withdraw Belviq at the request of the U.S. Food and Drug Administration. However, the company said in a...